Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Exploring Sox Gene Diversity in Brachyuran Crabs

February 3, 2026
Continue Reading
exploring-sox-gene-diversity-in-brachyuran-crabs
Posted inBiotechnology

Culture: The Key to Sustainable Food Systems

February 3, 2026
Continue Reading
culture:-the-key-to-sustainable-food-systems
Posted inBiotechnology

Tracking Mental Illness via Dynamic Brain Networks

February 3, 2026
Continue Reading
tracking-mental-illness-via-dynamic-brain-networks
Posted inBiotechnology

Culture: Key to Sustainable Food Systems Unveiled

February 3, 2026
Continue Reading
culture:-key-to-sustainable-food-systems-unveiled
Posted inBiotechnology

Phase 2 Trial Assesses c-Abl Inhibitor for Early Parkinson’s

February 3, 2026
Continue Reading
phase-2-trial-assesses-c-abl-inhibitor-for-early-parkinson’s
Posted inBiotechnology

Using Paid Sick Leave to Prevent Disease Spread

February 3, 2026
Continue Reading
using-paid-sick-leave-to-prevent-disease-spread
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

genetic-variability-of-voltage-gated-sodium-channel-nav1.2
Posted inBiotechnology

Genetic Variability of Voltage-Gated Sodium Channel NaV1.2

February 3, 2026
Voltage-gated sodium channels (VGSCs) are integral membrane proteins essential for the generation and propagation of action potentials in excitable cells.…
Read More
enhancing-medical-ai:-the-necessity-of-context-for-clinical-readiness
Posted inBiotechnology

Enhancing Medical AI: The Necessity of Context for Clinical Readiness

February 3, 2026
Medical artificial intelligence (AI) is rapidly evolving from a theoretical construct into a tangible instrument that has the potential to…
Read More
optimizing-energy-storage-in-homestay-renewable-networks
Posted inBiotechnology

Optimizing Energy Storage in Homestay Renewable Networks

February 3, 2026
The advent of renewable energy technologies has heralded a new era in energy distribution and management strategies. Energy storage systems,…
Read More
fda-signals-tailored-approach-to-‘carefully-shepherd’-car-t-therapy-for-autoimmune-diseases
Posted inBiotechnology

FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases

February 3, 2026
As the first CAR-T treatment for an autoimmune disease draws ever closer, officials at the FDA have signaled a willingness…
Read More
pfizer-ceo-says-pipeline-pruning-is-mostly-finished-after-6-more-early-stage-culls,-$4.4b-in-impairment-charges
Posted inBiotechnology

Pfizer CEO says pipeline pruning is mostly finished after 6 more early-stage culls, $4.4B in impairment charges

February 3, 2026
Pfizer has pumped the brakes on six early-stage assets, including three being tested for ulcerative colitis. The Big Pharma has…
Read More
fledgling-biotech-exxel-plans-$13m-ipo-to-succeed-where-other-faah-inhibitors-have-failed
Posted inBiotechnology

Fledgling biotech Exxel plans $13M IPO to succeed where other FAAH inhibitors have failed

February 3, 2026
Exxel Pharma is eyeing a listing on the NYSE American to fund human trials for a drug class that has…
Read More
pfizer’s-$10b-monthly-glp-1-bet-generates-competitive-weight-loss-in-phase-2b
Posted inBiotechnology

Pfizer’s $10B monthly GLP-1 bet generates competitive weight loss in phase 2b

February 3, 2026
Patients in a phase 2b trial kept losing weight after switching to monthly dosing of Pfizer’s GLP-1 receptor agonist, providing early…
Read More
speckle-echo-reveals-hidden-heart-issues-in-epileptic-kids
Posted inBiotechnology

Speckle Echo Reveals Hidden Heart Issues in Epileptic Kids

February 3, 2026
In a groundbreaking study that promises to reshape our understanding of drug-resistant epilepsy in children, researchers have revealed compelling evidence…
Read More
hcmv-infection-triggers-barrier-breakdown,-emt-in-cholangiocytes
Posted inBiotechnology

HCMV Infection Triggers Barrier Breakdown, EMT in Cholangiocytes

February 3, 2026
A groundbreaking study has unveiled the profound impacts of Human Cytomegalovirus (HCMV) infection on the integrity and function of cholangiocyte…
Read More
assessing-hip-fracture-risk:-costa-rica’s-unique-insights
Posted inBiotechnology

Assessing Hip Fracture Risk: Costa Rica’s Unique Insights

February 3, 2026
Hip fractures represent a significant public health concern worldwide, particularly as the global population ages. Recent research focusing on Costa…
Read More

Posts pagination

Previous page 1 2 3 4 5 6 … 1,374 Next page
You May Have Missed
quest-launches-residual-disease-blood-test-for-multiple-myeloma
Posted inMedical Technology

Quest launches residual disease blood test for multiple myeloma

optellum-tapped-by-nhs-for-ai-powered-lung-cancer-diagnostic-initiative
Posted inMedical Technology

Optellum tapped by NHS for AI-powered lung cancer diagnostic initiative

a-month-after-alcon-deal-fell-through,-staar-surgical-searches-for-next-ceo-and-names-interim-leaders
Posted inMedical Technology

A month after Alcon deal fell through, Staar Surgical searches for next CEO and names interim leaders

astrazeneca-study-finds-22-genes-tied-to-chronic-disease-risk-after-epstein-barr-infection
Posted inMedical Technology

AstraZeneca study finds 22 genes tied to chronic disease risk after Epstein-Barr infection

Privacy Policy    Terms

Scroll to Top